<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diabetic patients carry a four- to five-fold increased risk of <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0020456" disease_type="Disease or Syndrome" abbrv="">Hyperglycaemia</z:e> plays a central role in the pathogenesis of diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> represents a distinct structural and functional disorder of the myocardium characterized by <z:mp ids='MP_0001625'>cardiac hypertrophy</z:mp> and an increased myocardial stiffness </plain></SENT>
<SENT sid="3" pm="."><plain>At an early stage, diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> is manifested by diastolic <z:hpo ids='HP_0001635'>heart failure</z:hpo> with preserved ejection fraction </plain></SENT>
<SENT sid="4" pm="."><plain>In some patients, diastolic dysfunction may progress to <z:hpo ids='HP_0001635'>heart failure</z:hpo> with reduced ejection fraction and result in overt systolic <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Diastolic dysfunction can accurately be diagnosed by echocardiography and BNP measurement in daily clinical practice </plain></SENT>
<SENT sid="6" pm="."><plain>Early treatment is prognostically important </plain></SENT>
<SENT sid="7" pm="."><plain>Optimal control of blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels and blood pressure is beneficial </plain></SENT>
<SENT sid="8" pm="."><plain>So far <z:chebi fb="0" ids="6801">metformin</z:chebi> is the only <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> agent not associated with harm in diabetic patients with <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Incretin-based therapies potentially provide cardiovascular benefits </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="2" ids="35457">ACE inhibitors</z:chebi>, angiotensin-1 receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> and beta-blockers should be preferred in <z:hpo ids='HP_0001635'>heart failure</z:hpo> therapy </plain></SENT>
</text></document>